HEALTHGUARDIAN US
Judge rules FDA restrictions on mifepristone are arbitrary and capricious
A federal judge ruled that FDA restrictions on mifepristone, an abortion medication, are arbitrary and capricious, ordering the Trump administration to reconsider the restrictions. The judge affirmed the drug's safety and cited growing barriers to abortion access.
Mentioned
Related Signal
Adjacent reporting
- Federal judge says certain abortion drug restrictions are unlawful
- Opinion: Mifepristone court ruling makes drug development riskier for everyone
- An abortion ban won’t happen all at once — mifepristone is just the next phase
- Supreme Court keeps broader access to abortion pill mifepristone in place while legal fight continues
- Federal appeals court blocks mailing of abortion pills in ruling with nationwide effect